FUNC Score for ICH Functional Outcome
Predicts functional independence (Glasgow Outcome Scale ≥ 4) at 90 days after primary intracerebral haemorrhage (ICH). Used alongside the ICH Score to guide treatment decisions and goals-of-care discussions.
Score interpretation
FUNC ≤ 4: no patient achieved functional independence (GOS ≥ 4) at 90 days (Rost 2008).
→ Goals-of-care discussion with family is essential. Comfort measures vs aggressive care. Palliative care referral if appropriate.
FUNC 5–7: 13% functionally independent at 90 days (29% of survivors).
→ Shared decision-making with family regarding care goals. ICU if pursuing aggressive management. Neurosurgery review. Rehabilitation assessment early.
FUNC 8: 42% functionally independent at 90 days (48% of survivors).
→ Aggressive management appropriate. ICU/HDU care. Neurosurgery review (evacuation if cerebellar ≥ 3 cm). BP management. Early rehabilitation planning.
FUNC 9–10: 66% functionally independent at 90 days (75% of survivors).
→ Aggressive management appropriate. ICU/HDU care. Neurosurgery review (evacuation if cerebellar ≥ 3 cm). BP management. Early rehabilitation planning.
FUNC 11: 82% functionally independent at 90 days (95% of survivors).
→ Aggressive management appropriate. ICU/HDU care. Neurosurgery review (evacuation if cerebellar ≥ 3 cm). BP management. Early rehabilitation planning.
Interpretation bands for the FUNC Score. Apply clinical judgement and local guidance.
References
- Rost NS, et al. Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke. 2008;39(8):2304–2309.
Related
Curated clinical cross-links plus same-class fallbacks.
- Aspirin (Loading Dose) · Antiplatelet — ACS / Ischaemic Stroke
- Alteplase (tPA) · Thrombolytic — Ischaemic Stroke / Massive PE
- Edoxaban (AF Stroke Prevention / VTE) · Direct Factor Xa Inhibitor (DOAC)
- Clopidogrel (Stroke/TIA Secondary Prevention) · Antiplatelet (P2Y12 Inhibitor)
- Dabigatran (Stroke Prevention — AF) · Direct Oral Anticoagulant — Thrombin Inhibitor
- Rivaroxaban (Stroke Prevention — AF) · Direct Oral Anticoagulant — Factor Xa Inhibitor
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.
